Why the study?
Does dilazep or d-propranolol prevent lysophosphatidylcholine-induced mechanical and metabolic derangements in isolated rat hearts?
Does dilazep or d-propranolol prevent lysophosphatidylcholine-induced mechanical and metabolic derangements in isolated rat hearts?
Dilazep and d-propranolol can prevent lysophosphatidylcholine-induced ischemia-like myocardial damage in isolated rat hearts.
Attenuates LPC-induced damage in isolated rat hearts; hypothesis-generating, human translation untested.
The effects of dilazep, d-propranolol and lidocaine on the mechanical and metabolic changes induced by lysophosphatidylcholine (LPC) were studied in isolated, perfused working rat heart. After a stabilization period, the heart was perfused for 5 min with LPC (10 microM) alone, LPC plus dilazep (5, 10 or 20 microM), LPC plus d-propranolol (30 or 50 microM) or LPC plus lidocaine (30 or 100 microM) and then perfused with normal Krebs-Henseleit bicarbonate (KHB) buffer for a further 20 min. Perfusion with LPC for 5 min followed by KHB for 20 min irreversibly decreased cardiac mechanical function, decreased the tissue levels of adenosine triphosphate and creatine phosphate significantly, and increased the tissue levels of lactate and free fatty acids including arachidonic acid. Dilazep or d-propranolol significantly attenuated the mechanical and metabolic changes induced by LPC, but lidocaine did not. These results indicate that the exogenous LPC causes ischemia-like changes, suggesting that LPC is one of the important factors in producing ischemia-reperfusion derangements in terms of mechanical and metabolic functions, and that both dilazep and d-propranolol can prevent the LPC-induced myocardial damage.
No takes yet. Share an insight, caveat, or question.
Hoque et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: